Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.
Alexandria Real Estate Equities, Inc., is a mission-driven life science REIT. The firm is pioneered the life science real estate niche. The firm is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. Alexandria Real Estate Equities, Inc. was established on 5th January 1994 and was incorporated in Maryland.
Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →
| Compte de résultat | TTM → 2026-09-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiffre d'affaires total | $2.7B | $3.0B | $3.0B | $2.8B | $2.6B | $2.1B | $1.9B | $1.5B | $1.3B | $1.1B | $898M | $820M | $727M | $631M | $586M | $510M | $487M | $491M | ($79M) | $317M | $245M |
| Bénéfice brut | $1.8B | $2.0B | $2.1B | $2.0B | $1.8B | $1.5B | $1.4B | $1.1B | $946M | $799M | $619M | $558M | $508M | $442M | $412M | $341M | $355M | $371M | ($193M) | $218M | $245M |
| Marge brute % | 67.3% | 68.9% | 70.2% | 69.8% | 69.6% | 70.5% | 71.9% | 70.9% | 71.3% | 71.0% | 69.0% | 68.1% | 69.8% | 70.0% | 70.2% | 66.9% | 72.9% | 75.5% | 245.4% | 68.7% | 100.0% |
| Résultat opérationnel (EBIT) | ($1.3B) | ($1.2B) | $770M | $690M | $613M | $530M | $532M | $443M | $422M | $181M | $41M | $137M | $181M | $131M | $103M | $195M | $205M | $216M | $202M | $182M | $145M |
| Marge opérationnelle % | -48.8% | -40.5% | 25.2% | 24.3% | 23.8% | 25.1% | 28.2% | 28.9% | 31.8% | 16.1% | 4.6% | 16.7% | 24.9% | 20.8% | 17.6% | 38.2% | 42.0% | 43.9% | -255.9% | 57.5% | 59.0% |
| Résultat net | ($1.4B) | ($1.4B) | $323M | $104M | $522M | $571M | $771M | $363M | $379M | $169M | ($66M) | $144M | $102M | $136M | $102M | $131M | $135M | $135M | $116M | $94M | $73M |
| Marge nette % | -51.2% | -48.1% | 10.6% | 3.6% | 20.2% | 27.0% | 40.9% | 23.7% | 28.6% | 15.0% | -7.3% | 17.6% | 14.0% | 21.6% | 17.4% | 25.8% | 27.8% | 27.4% | -147.6% | 29.6% | 29.9% |
| EBITDA | — | $360M | $1.9B | $1.4B | $1.8B | $1.4B | $1.2B | $987M | $900M | $611M | $264M | $407M | $323M | $324M | $290M | $294M | $206M | $323M | $312M | $275M | $223M |
| Bénéfice par action (EPS) | $-8.41 | $-8.40 | $1.88 | $0.61 | $3.23 | $3.87 | $6.10 | $3.23 | $3.67 | $1.84 | $-0.87 | $2.02 | $1.43 | $2.00 | $1.64 | $2.22 | $2.80 | $3.49 | $3.64 | $3.12 | $2.88 |
| Actions en circulation (M) | — | 170M | 172M | 171M | 162M | 147M | 126M | 113M | 103M | 92M | 76M | 72M | 71M | 68M | 62M | 59M | 48M | 39M | 32M | 30M | 25M |
Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.
Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de ARE. /companies/us/ARE
Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.
About TickerBase · Data methodology & sources · Privacy · Terms